Successful management of nose arterial occlusion and impending skin necrosis after filler injection

• 발행기관: 대한미용의학회
• 저자명: Lenzo Ing Heong Ling
• 간행물 정보: 『Journal of Cosmetic Medicine』Vol.3, No.2, 108~113쪽, 전체 6쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2019.12.30

영문 초록

The growing use of dermal fillers, specifically the use of hyaluronic acid, may be explained by their effectiveness and versatility and their favorable safety profiles. Nevertheless, early and late complications with varying levels of severity may occur. The incidence of complications is low; however, more severe events such as skin ischemia and necrosis, and even visual loss may occur. The main objective of this case report on intravascular filler injection was to provide information on early signs of ischemic skin necrosis to physicians administering cosmetic fillers. This knowledge will facilitate timely management of symptoms, and enable treatment with hyperbaric oxygen therapy (HBOT) to prevent permanent scarring. A case note study of a single 41-year-old female who underwent a combination of treatments including the “high-dose pulsed hyaluronidase” technique, intravenous dexamethasone, HBOT, open dressing with normal saline, and bactigras dressing. Early recognition and immediate application of the correct combination of treatments for intravascular filler injury prevented further skin necrosis, permanent scarring, and the requirement for surgical reconstruction. Recently, as the application of dermal fillers for soft-tissue augmentation has increased, the number of cases reporting adverse reactions has also increased. The most severe and alarming early complication is vascular occlusion. Thus, it is crucial that physicians are familiar with the anatomy of the treated region, type of product used, correct application technique, and possible adverse events to allow immediate recognition and treatment.

목차

Introduction

Case report

Discussion

Conclusion

Conflicts of interest

References

키워드

arterial embolization dermal filler injection hyperbaric oxygen therapy skin necrosis vascular compromise